Keyphrases
Chimeric Antigen Receptor T Cells (CAR-T)
100%
T Cells
56%
Co-stimulatory Domain
44%
T Cell Depletion
44%
Cohesin
44%
Genome Editing
33%
Oncolytic
29%
Axonal Degeneration
27%
CD19
26%
Glycosylation
22%
Receptor Design
22%
T Cell Targeting
22%
DNA Methylation (DNAm)
22%
Microtubules
22%
Virotherapy
22%
Pds5
22%
Liver Tumor
22%
Regulatory Factors
22%
Protein Cleavage
22%
Nicotinamide Adenine Dinucleotide (NAD+)
22%
Genetic Therapy
22%
Hepatic Neoplasm
22%
Oncolytic Virotherapy
22%
Head-and-neck Cancer
22%
CCCTC-binding Factor
22%
Dosage Effect
22%
Nicotinamide Mononucleotide Adenylyltransferase (NMNAT)
22%
Viral Therapy
22%
Neuronal Culture
22%
Tubulin Acetylation
22%
Amyloid Precursor Protein
22%
Cohesinopathy
22%
PDS5B
22%
Mammalian Development
22%
Regulatory Approval
22%
Adoptive Cell Therapy
22%
Synthetic Antigen
22%
Antigen Receptor
22%
T Cell Activation
19%
Recent Advances
18%
Oncolysis
18%
Therapeutic Transgene
18%
Cancer-specific
18%
Novel Therapies
18%
Virus Spread
18%
Cancer Cells
18%
Virus Infection
18%
Therapeutic Class
18%
Transgene Expression
16%
Endogenous Genes
16%
Medicine and Dentistry
Chimeric Antigen Receptor
77%
T Cell
74%
Gene Therapy
44%
Chimeric Antigen Receptor T-Cell
39%
Clinical Study
37%
Neoplasm
33%
Virotherapy
29%
Transgene
25%
Cancer
25%
B Cell
23%
Glycosylation
22%
Liver Tumor
22%
Oncolytic Virotherapy
22%
Malignant Neoplasm
22%
Head and Neck Cancer
22%
Cell Therapy
22%
Synthetic Antigen
22%
Cell Function
17%
Peptidase
16%
Signal Peptide
16%
Virus
14%
Infection
14%
Cancer Cell
14%
Chimeric Antigen Receptor Immunotherapy
12%
Diseases
12%
Personalized Medicine
11%
Combination Therapy
11%
Biological Functions
11%
Genome Editing
11%
T Lymphocyte
11%
Clustered Regularly Interspaced Short Palindromic Repeat
11%
Antigen Recognition
7%
Cell Protein
7%
T Cell Activation
7%
Immunocompetent Cell
7%
Antigen Specificity
7%
Peptide Fragment
7%
Tumor Cell
7%
Tumor Suppressor Gene
7%
Programmed Cell Death
7%
Pharmacophore
7%
Carcinogenesis
7%
Liver Cancer
7%
Virus Replication
7%
Gendicine
7%
Virotherapy Agent
7%
Cancer Treatment
7%
Oncolytic Virus
7%
Proteinase
5%
Chimeric Antigen Receptor T-Cell Immunotherapy
5%